These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 25976906)

  • 1. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
    Landolina M; Morani G; Curnis A; Vado A; D'Onofrio A; Bianchi V; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2017 Aug; 19(8):1349-1356. PubMed ID: 27702861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.
    von Gunten S; Schaer BA; Yap SC; Szili-Torok T; Kühne M; Sticherling C; Osswald S; Theuns DA
    Europace; 2016 May; 18(5):710-7. PubMed ID: 26609076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device Longevity in a Contemporary Cohort of ICD/CRT-D Patients Undergoing Device Replacement.
    Zanon F; Martignani C; Ammendola E; Menardi E; Narducci ML; DE Filippo P; Santamaria M; Campana A; Stabile G; Potenza DR; Pastore G; Iori M; LA Rosa C; Biffi M
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):840-5. PubMed ID: 27094359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ampere Hour as a Predictor of Cardiac Resynchronization Defibrillator Pulse Generator Battery Longevity: A Multicenter Study.
    Ellis CR; Dickerman DI; Orton JM; Hassan S; Good ED; Okabe T; Andriulli JA; Quan KJ; Greenspon AJ
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):658-68. PubMed ID: 26875541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports.
    Alam MB; Munir MB; Rattan R; Adelstein E; Jain S; Saba S
    Europace; 2017 Mar; 19(3):421-424. PubMed ID: 27009183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world data on the lifespan of implantable cardioverter-defibrillators depending on manufacturers and the amount of ventricular pacing.
    Horlbeck FW; Mellert F; Kreuz J; Nickenig G; Schwab JO
    J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1336-42. PubMed ID: 22909190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.
    Thijssen J; Borleffs CJ; van Rees JB; Man S; de Bie MK; Venlet J; van der Velde ET; van Erven L; Schalij MJ
    Heart Rhythm; 2012 Apr; 9(4):513-9. PubMed ID: 22094073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
    Knops P; Theuns DA; Res JC; Jordaens L
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1276-85. PubMed ID: 19796344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longevity of implantable cardioverter-defibrillators in a single-center population.
    Seegers J; Expósito PM; Lüthje L; Fischer T; Lueken M; Wenk H; Sossalla ST; Hasenfuss G; Zabel M
    J Interv Card Electrophysiol; 2015 Nov; 44(2):179-86. PubMed ID: 26253815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.
    Biffi M; Ziacchi M; Bertini M; Sangiorgi D; Corsini D; Martignani C; Diemberger I; Boriani G
    Europace; 2008 Nov; 10(11):1288-95. PubMed ID: 18772164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturer change and risk of system-related complications after implantable cardioverter defibrillator replacement: physicians' survey and data from the Detect Long-term Complications After Implantable Cardioverter Defibrillator Replacement Registry.
    Biffi M; Menardi E; Narducci ML; Ammendola E; Messano L; Giofrè F; Baiocchi C; Saporito D; Lissoni F; Bertini M; Pierantozzi A; Zingarini G; Malacrida M; Ziacchi M
    J Cardiovasc Med (Hagerstown); 2017 Dec; 18(12):968-975. PubMed ID: 29028784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of battery longevity on costs and health outcomes associated with cardiac implantable electronic devices: a Markov model-based Monte Carlo simulation.
    Schmier JK; Lau EC; Patel JD; Klenk JA; Greenspon AJ
    J Interv Card Electrophysiol; 2017 Nov; 50(2):149-158. PubMed ID: 29110166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac implantable electronic device reutilization: battery life of explanted devices at a tertiary care center.
    Gakenheimer L; Romero J; Baman TS; Montgomery D; Smith CA; Oral H; Eagle KA; Crawford T
    Pacing Clin Electrophysiol; 2014 May; 37(5):569-75. PubMed ID: 24359248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.
    Doppalapudi H; Barrios J; Cuellar J; Gannon M; Yamada T; Kumar V; Maddox WR; Plumb VJ; Brown TM; McElderry HT
    J Cardiovasc Electrophysiol; 2017 May; 28(5):552-558. PubMed ID: 28181727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Device Histogram-Based Simple Predictor of Mortality Risk in ICD and CRT-D Patients: The Heart Rate Score.
    Wilkoff BL; Richards M; Sharma A; Wold N; Jones P; Perschbacher D; Olshansky B
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):333-343. PubMed ID: 28156008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.